Rheumatic diseases in China.
Rheumatic diseases in China.
复制标题
DOI：
10.1186/ar2368
复制
发表时间：
2008
影响因子：
4.9
通讯作者：
Zhang NZ
中科院分区：
文献类型：
--
作者：
Zeng QY;Chen R;Darmawan J;Xiao ZY;Chen SB;Wigley R;Le Chen S;Zhang NZ
我国近20年来开展了风湿病的流行病学研究。本研究的目的是了解中国常见风湿性疾病的患病率。检索了1980年至2006年进行的基于人口的调查的相关报告。识别并分析了使用世界卫生组织-国际风湿病协会联盟COPCORD（风湿病控制社区导向计划）方案的研究以及未使用该方案但在公认期刊上发表的研究。来自25个省/市的38份调查，包括241，169名成年人进行了汇总分析。风湿病的患病率范围为11.6%至46.4%，因地区、研究方案和受调查者的年龄而异。症状性骨关节炎（OA）的患病率为5.1%至20.8%，常见受累部位为腰椎、膝关节和颈椎。与美国的影像学和症状性膝关节OA的患病率相比，北京的老年男性的患病率相似，老年女性的患病率更高。髋关节OA和手部OA的患病率在中国人群中远低于白人人群，但这两种OA在煤矿工人中更常见。汉族强直性脊柱炎的患病率范围为0.2%至0.54%，混合民族人群的患病率较低。银屑病关节炎的患病率为0.01%至0.1%，反应性关节炎的患病率为0.02%;在调查中，0.64%至1.2%的个体中发现了未分化的脊柱关节病。类风湿性关节炎（RA）的患病率范围为0.2%至0.93%，其中台湾城市地区的患病率最高。在中国大陆，RA的患病率在中国北方和南方之间以及不同民族之间没有显著差异。高尿酸血症的患病率在20世纪80年代后增加。痛风的盛行率在近十年来由0.15%增加至1.98%，但台湾原住民的盛行率最高，达11.7%。北京地区原发性干燥综合征的患病率按哥本哈根标准为0.77%，按圣地亚哥标准为0.33%。软组织风湿病患病率为2.5%~ 5.7%。纤维肌痛在我国少见。风湿病在中国很常见。风湿病的患病率随调查地点的不同而不同。OA的患病率与西方国家相当，但在关节受累方面有所不同。强直性脊柱炎的患病率与高加索人相似。除台湾地区外，我国RA的患病率均低于发达国家。高尿酸血症和痛风的患病率在20世纪80年代后有所增加，但仍低于发达国家。需要更多的研究来评估中国西部和西北部少数民族人群的患病率，并需要进一步研究来解决中国的纤维肌痛问题。
Epidemiological studies of rheumatic diseases have been conducted during the past 20 years in China. The aim of this study was to clarify prevalence rates of common rheumatic diseases in China. Relevant reports of population-based surveys conducted from 1980 to 2006 were retrieved. Studies using the World Health Organization-International League of Associations for Rheumatology COPCORD (Community Oriented Program for Control of Rheumatic Diseases) protocol and those that did not employ this protocol but were published in recognized journals were identified and analyzed. Thirty-eight surveys including 241,169 adults from 25 provinces/cities were pooled for analysis. The prevalence of rheumatic complaints ranged from 11.6% to 46.4%, varying by locality, study protocol and age of the people surveyed. Prevalence of symptomatic osteoarthritis (OA) varied from 5.1% to 20.8%, with common sites of involvement being the lumbar spine, knee joint and cervical spine. Compared with rates of radiographic and symptomatic knee OA in the USA, elderly men in Beijing exhibited similar prevalence rates and elderly women exhibited a higher prevalence. The prevalence of hip OA and hand OA was much lower in Chinese than in Caucasian populations, but both kinds of OA were more common in coal miners. The prevalence of ankylosing spondylitis ranged from 0.2% to 0.54% among Han ethnic Chinese and were lower among mixed ethnic populations. The prevalence of psoriatic arthritis ranged from 0.01% to 0.1%, and that of reactive arthritis was 0.02%; undifferentiated spondyloarthropathy was identified in 0.64% to 1.2% of the individuals included in the surveys. The prevalence of rheumatoid arthritis (RA) ranged from 0.2% to 0.93%, with the highest rate being reported from a Taiwan urban area. In mainland China there were no significant differences in prevalence of RA between the northern and southern parts of China, or between different ethnic groups. The prevalence of hyperuricemia increased after the 1980s. The prevalence of gout was found to have increased in recent decades from 0.15% to 1.98%, apart from in the Taiwan aborigines, among whom the highest prevalence rate of 11.7% was recorded. The prevalence of primary Sjögren's syndrome in Beijing was 0.77% by the Copenhagen criteria and 0.33% by the San Diego criteria. The prevalence of soft tissue rheumatism was 2.5% to 5.7%. Fibromyalgia was seldom observed in China. Rheumatic diseases are common in China. The prevalence of rheumatic complaints varied with the locality surveyed. The prevalence of OA is comparable with that in Western countries but varies in terms of joint involvement. The prevalence of ankylosing spondylitis is similar to that in Caucasians. Except in Taiwan, the prevalence of RA in China is lower than that in developed countries. The prevalence of hyperuricemia and gout increased after the 1980s, but it remains lower than that in developed countries. More studies are required to evaluate prevalence rates among minority groups in the west and northwest parts of China, and further study is needed to address fibromyalgia in China.
登录
查看更多内容
影响因子：
4
作者：
Du, H;Chen, SL;Nishioka, K
通讯作者：
Nishioka, K
纤维肌痛的生物学和治疗。纤维肌痛综合征的遗传方面。
影响因子：
4.9
作者：
Buskila, Dan;Sarzi-Puttini, Piercarlo
通讯作者：
Sarzi-Puttini, Piercarlo
影响因子：
27.4
作者：
GRAN, JT;HUSBY, G;HORDVIK, M
通讯作者：
HORDVIK, M
影响因子：
27.4
作者：
DARMAWAN, J;VALKENBURG, HA;WIGLEY, RD
通讯作者：
WIGLEY, RD
影响因子：
--
作者：
CARTER, ET;MCKENNA, CH;KURLAND, LT
通讯作者：
KURLAND, LT